Corticosteroid use in viral pneumonia: experience so far and the dexamethasone breakthrough in coronavirus disease-2019

Dexamethasone was shown to decrease the mortality in coronavirus disease-2019 (COVID-19) recently. Use of corticosteroids was harmful in other coronavirus infections previously. WHO recommended against routine use of corticosteroids in COVID-19. In view of these, we reviewed the evidence about the u...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafiullah, Mohamed, Siddiqui, Khalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694443/
https://www.ncbi.nlm.nih.gov/pubmed/33245242
http://dx.doi.org/10.2217/cer-2020-0146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694443/
https://www.ncbi.nlm.nih.gov/pubmed/33245242
http://dx.doi.org/10.2217/cer-2020-0146

Ejemplares similares